参考文献:1. Eriksson KS, Panula P (1994) gamma-Aminobutyric acid in the nervous system of a planarian. J Comp Neurol 345:528–536 2. Kusayama T, Watanabe S (2000) Reinforcing effects of methamphetamine in planarians. Neuroreport 11:2511–2513 3. Nagel J, Belozertseva I, Greco S, Kashkin V, Malyshkin A, Jirgensons A, Shekunova E, Eilbacher B, Bespalov A, Danysz W (2006) Effects of NAAG peptidase inhibitor 2-PMPA in model chronic pain-relation to brain concentration. Neuropharmacology 51:1163–1171 4. Neale JH, Olszewski RT, Gehl LM, Wroblewska B, Bzdega T (2005) The neurotransmitter N-acetylaspartylglutamate in models of pain, ALS, diabetic neuropathy, CNS injury and schizophrenia. Trends Pharmacol Sci 26:477–484 5. Nishimura K, Kitamura Y, Taniguchi T, Agata K (2010) Analysis of motor function modulated by cholinergic neurons in planarian Dugesia japonica. Neuroscience 168:18–30 6. Pag谩n OR, Rowlands AL, Azam M, Urban KR, Bidja AH, Roy DM, Feeney RB, Afshari LK (2008) Reversal of cocaine-induced planarian behavior by parthenolide and related sesquiterpene lactones. Pharmacol Biochem Behav 89:160–170 7. Palladini G, Ruggeri S, Stocchi F, De Pandis MF, Venturini G, Margotta V (1996) A pharmacological study of cocaine activity in planaria. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 115:41–45 8. Raffa RB, Rawls SM (2008) A model for drug action and abuse. Landes Bioscience, Austin 9. Raffa RB, Valdez JM (2001) Cocaine withdrawal in planaria. Eur J Pharmacol 430:143–145 10. Rawls SM, Thomas T, Adeola M, Patil T, Raymondi N, Poles A, Loo M, Raffa RB (2009) Topiramate antagonizes NMDA- and AMPA-induced seizure-like activity in planarians. Pharmacol Biochem Behav 93:363–367 11. Rawls SM, Karaca F, Madhani I, Bhojani V, Martinez RL, Abou-Gharbia M, Raffa RB (2010) β-lactamase inhibitors display anti-seizure properties in an invertebrate assay. Neuroscience 169:1800–1804 12. Rowlands AL, Pag谩n OR (2008) Parthenolide prevents the expression of cocaine-induced withdrawal behavior in planarians. Eur J Pharmacol 583:170–172 13. Slusher BS, Vornov JJ, Thomas AG, Hurn PD, Harukuni I, Bhardwaj A, Traystman RJ, Robinson MB, Britton P, Lu XC, Tortella FC, Wozniak KM, Yudkoff M, Potter BM, Jackson PF (1999) Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury. Nat Med 5:1396–1402 14. Slusher BS, Thomas A, Paul M, Schad CA, Ashby CR Jr (2001) Expression and acquisition of the conditioned place preference response to cocaine in rats is blocked by selective inhibitors of the enzyme N-acetylated-alpha-linked-acidic dipeptidase (NAALADASE). Synapse 41:22–28 15. Thomas AG, Bodner A, Ghadge G, Roos RP, Slusher BS (2009) GCP II inhibition rescues neurons from gp120IIIB-induced neurotoxicity. J Neurovirol 15:449–457 16. Urazaev AK, Grossfeld RM, Lieberman EM (2005) Regulation of glutamate carboxypeptidase II hydrolysis of N-acetylaspartylglutamate (NAAG) in crayfish nervous tissue is mediated by glial glutamate and acetylcholine receptors. J Neurochem 93:605–610 17. Vyas CA, Rawls SM, Raffa RB, Shackman JG (2011) Glutamate and aspartate measurements in individual planaria by rapid capillary electrophoresis. J Pharmacol Toxicol Methods 63:199–222 18. Witkin JM, Gasior M, Schad C, Zapata A, Shippenberg T, Hartman T, Slusher BS (2002) NAALADase (GCP II) inhibition prevents cocaine-kindled seizures. Neuropharmacology 43:348–356 19. Xi ZX, Li X, Peng XQ, Li J, Chun L, Gardner EL, Thomas AG, Slusher BS, Ashby CR Jr (2010a) Inhibition of NAALADase by 2-PMPA attenuates cocaine-induced relapse in rats: a NAAG-mGluR2/3-mediated mechanism. J Neurochem 112:564–576 20. Xi ZX, Kiyatkin M, Li X, Peng XQ, Wiggins A, Spiller K, Li J, Gardner EL (2010b) N-acetylaspartylglutamate (NAAG) inhibits intravenous cocaine self-administration and cocaine-enhanced brain-stimulation reward in rats. Neuropharmacology 58:304–313
作者单位:1. Department of Pharmaceutical Sciences, Temple University Health Sciences Center, 3307 North Broad Street, Philadelphia, PA 19140, USA2. Center for Substance Abuse Research, Temple University, Philadelphia, PA 19140, USA
Glutamate carboxypeptidase II (GCPII) inhibitors are promising anti-glutamatergic and anti-addictive agents. We hypothesized that a GCPII inhibitor 2 (phosphonomethyl) pentanedioic acid (2-PMPA) would display anti-stereotypical activity in planarians. Experiments revealed that 2-PMPA displayed no overt behavioral activity by itself but attenuated stereotypical counts (C-shape hyperkinesias) elicited by four compounds (2-PMPA rank order potency: glutamate > NMDA > pilocarpine > cocaine). These data suggest GCPII inhibitors display broad-spectrum efficacy against behavioral activity produced by glutamatergic and non-glutamatergic compounds in an invertebrate assay.